Overview
BioDlink (TOT BIOPHARM)’s GMP production base is equipped with multiple complete upstream and downstream production lines, ensuring efficient, quality controlled and flexible switching between different product productions.
With an integrated platform for ADC/Bioconjugates, critical production steps—such as antibody production, ADC/bioconjugates drug substance (DS) and drug product (DP) manufacturing —are completed at a single site, reducing transfer and regulatory risks.
This platform has supported and continues to support the commercial production of two marketed products.